| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/27/2005 | CN1198924C Expression cloning in filamentous fungi |
| 04/27/2005 | CN1198836C Nucleic acids encoding G-protein coupled receptor involved in sensory |
| 04/27/2005 | CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof |
| 04/26/2005 | US6885196 Biosensor |
| 04/26/2005 | US6884779 Hybrid screening analyzing |
| 04/26/2005 | US6884620 Genetic engineering |
| 04/26/2005 | US6884618 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 04/26/2005 | US6884601 Using phospholipid hydroperoxide glutathione peroxidase concentrations to diagnose sex/reproductive disorders in mammals; in vitro fertility |
| 04/26/2005 | US6884599 Kit for the determination of L-carnitine in biological fluids and tissues |
| 04/26/2005 | US6884598 Screening for modulator of receptor binding activity; obtain cells, incubate with modulator, monitor cell response |
| 04/26/2005 | US6884597 Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or enhancers of these enzymes |
| 04/26/2005 | US6884595 Test tumor cell modulation; analyzing chromosomes |
| 04/26/2005 | US6884590 Kit for detecting restriction fragnemt length polymorphism in intracellular adhesion molecules and diagnosing inflammatory bowel disease |
| 04/26/2005 | US6884588 Using oligonucleotide primers sequences to identify and detect bacterial based chemical and biological warfare agents |
| 04/26/2005 | US6884586 Methylation analysis using nicking agents |
| 04/26/2005 | US6884584 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 04/26/2005 | US6884583 Detecting preferential nucleotide sequences in sample; obtain nucleotide sequence sample, incubate with primers and probes, amplify nucleotide sequences, detect hybridization signal from probes |
| 04/26/2005 | US6884582 Using photothermography to identify protein/ligand interactions; rational drug design and discovery |
| 04/26/2005 | US6884581 Method for identifying a test compound that modulates expression of a Fra-1 gene in a brain cancer cell |
| 04/26/2005 | US6884578 The gene expression differences thus identified can be used to diagnose disease, identify physiological state, design drugs, and monitor therapies. |
| 04/26/2005 | US6884577 Methods for screening compounds for estrogenic activity |
| 04/26/2005 | US6884576 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 04/26/2005 | US6884575 Diagnosis and treatment of insulin resistance in diabetics; obtain humans, administer modulator of insulin resistance, monitor human response to insulin |
| 04/26/2005 | US6884574 Methods of identifying agents which inhibit GPR-9-6 |
| 04/26/2005 | US6884395 Thermocycling reaction for nucleic acid template purification; gel filtration; electrophoretic separation |
| 04/26/2005 | US6883958 For collecting and processing specimens of particulate matter-containing biological fluid, including depositing onto microscope slide or other surface a uniform layer of particulates therefrom (e.g., cells); diagnostic cytology |
| 04/26/2005 | CA2395627C Imaging and analyzing parameters of small moving objects such as cells |
| 04/26/2005 | CA2253871C Ret ligand (retl) for stimulating neural and renal growth |
| 04/26/2005 | CA2062753C Precipitate test for microorganisms |
| 04/22/2005 | CA2485722A1 Soluble transferrin receptor |
| 04/22/2005 | CA2485718A1 Differential diagnosis with hepcidin |
| 04/21/2005 | WO2005036602A2 Integrated biochip with continuous sampling and processing (csp) system |
| 04/21/2005 | WO2005036169A2 Fluorescent probes for ribosomes and method of use |
| 04/21/2005 | WO2005036168A2 Method of detecting biological materials in liquid |
| 04/21/2005 | WO2005036156A1 Detection of molecular interactions using a metal-insulator-semiconductor diode structure |
| 04/21/2005 | WO2005036133A2 Electrode-based detection of polynucleotides |
| 04/21/2005 | WO2005036128A2 Bacterial lethality test indicator and prompt response spectroscopic analyzer |
| 04/21/2005 | WO2005036126A2 Apparatus and methods for fluorescent detection of nucleic acids |
| 04/21/2005 | WO2005035794A2 Detection of prrsv |
| 04/21/2005 | WO2005035793A2 Cckar markers and haplotypes associated with extreme weight conditions |
| 04/21/2005 | WO2005035791A1 Methods to increase nucleotide signals by raman scattering |
| 04/21/2005 | WO2005035790A1 Method and apparatus for recognizing molecular compounds |
| 04/21/2005 | WO2005035789A1 Primer for detecting alicyclobacillus |
| 04/21/2005 | WO2005035788A2 Method and kit for assessing anxiety or disposition thereto in a subject |
| 04/21/2005 | WO2005035787A1 Molecular detection of mycobacterium avium subsp. paratuberculosis |
| 04/21/2005 | WO2005035786A2 Methods for the risk estimation of bronchiectasis using ifngamma and cxcr1 gene polymorphisms |
| 04/21/2005 | WO2005035785A2 Method for the rapid detection of micro-organisms on dna chips |
| 04/21/2005 | WO2005035784A1 A diagnostic method for neonatal or infantile epilepsy syndromes |
| 04/21/2005 | WO2005035783A1 Fluorescense based bioassay for anti-parasitic drugs |
| 04/21/2005 | WO2005035782A1 Method of classifying chemical agents and identifying cellular targets thereof |
| 04/21/2005 | WO2005035781A1 Prebiotic effect analysis |
| 04/21/2005 | WO2005035760A2 Molecular nanomotor |
| 04/21/2005 | WO2005035725A2 Methods for prenatal diagnosis of chromosomal abnormalities |
| 04/21/2005 | WO2005035724A2 Cancer-linked genes as targets for chemotherapy |
| 04/21/2005 | WO2005035719A2 Modified luciferase |
| 04/21/2005 | WO2005035718A2 Biderectional promoters for small rna expression |
| 04/21/2005 | WO2005035715A2 Flanking dna sequences that control expression in the human genome |
| 04/21/2005 | WO2005035711A2 Culture medium for rapid detection of mycobacterial growth by color change |
| 04/21/2005 | WO2005035579A1 A method for the treatment of maligant diseases by inhibiting nucleolin |
| 04/21/2005 | WO2005035556A2 Sars-coronavirus virus-like particles and methods of use |
| 04/21/2005 | WO2005035547A2 E2f oligonucleotide decoy molecules |
| 04/21/2005 | WO2005035545A2 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | WO2005034853A2 Uses of interferons with altered spatial structure |
| 04/21/2005 | WO2005034840A2 Identification of kinase inhibitors |
| 04/21/2005 | WO2005034737A2 Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases |
| 04/21/2005 | WO2005034735A2 Method for assessing the risk for insulin resistant diabetes and/or heart disease |
| 04/21/2005 | WO2005034732A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | WO2005034719A2 Candidate genes, pathways and mechanisms for bipolar and related disorders |
| 04/21/2005 | WO2005021800A3 Detection and quantitation of nucleic acid molecules in biological samples |
| 04/21/2005 | WO2005019427A3 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 04/21/2005 | WO2005017197A3 Method for early detection and monitoring of diseases by analysis of cell-surface-bound nucleic acids |
| 04/21/2005 | WO2005017129B1 Phosphoramide and uses thereof |
| 04/21/2005 | WO2005014789A3 Tandem repeat determination by concurrent analysis of multiple tandem duplex configurations |
| 04/21/2005 | WO2005007880A8 Pknb kinase and pstp phosphatase and methods of identifying inhibitory substances |
| 04/21/2005 | WO2005007677A3 Affinity capture of peptides by microarray and related methods |
| 04/21/2005 | WO2005007279A3 Compounds for changing the physical properties of ice and methods of use thereof |
| 04/21/2005 | WO2005003776A3 In vitro methods for detecting renal cancer |
| 04/21/2005 | WO2005001118A3 Detection system |
| 04/21/2005 | WO2004111610A3 Method and system for the analysis of high density cells samples |
| 04/21/2005 | WO2004109286A3 Methods for detecting and treating cancer using podocalyxin and/or endoglycan |
| 04/21/2005 | WO2004108951A8 Methods for assessing the invasive potential of a cell employing chromatin analysis |
| 04/21/2005 | WO2004108902A3 Biocompatible fluorescent silicon nanoparticles |
| 04/21/2005 | WO2004106544A3 Optical sensors based on hybrid aptamer/conjugated polymer complexes |
| 04/21/2005 | WO2004104199A3 Modulation of gene expression using dna-dna hybrids |
| 04/21/2005 | WO2004103512A3 Method and system for electrokinetic, preparative sample separation in high-surface-area separation channels with non-convex cross sections |
| 04/21/2005 | WO2004103268A3 Intracellular production of specific rna molecules by splicing |
| 04/21/2005 | WO2004099447A3 Corn event tc1507 and methods for detection thereof |
| 04/21/2005 | WO2004098490A3 Mesoderm and definitive endoderm cell populations |
| 04/21/2005 | WO2004096987A3 A forward mutation assay based on 5-fluorouracil resistance |
| 04/21/2005 | WO2004094608A3 Human procolipase like nucleic acids and polypeptides and their methods of use threof |
| 04/21/2005 | WO2004092734A3 Novel approach to molecular diagnosis of human papilloma virus-related diseases |
| 04/21/2005 | WO2004089423A3 Pharmico-gene theraphy of epithelial sodium channel associated disoders |
| 04/21/2005 | WO2004087746A3 Staphylococcus epidermidis antigens |
| 04/21/2005 | WO2004085681A3 Global linear non-biased nucleic acid amplification |
| 04/21/2005 | WO2004083388A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
| 04/21/2005 | WO2004080378A3 Methods and tools for screening active rna in cellulo |
| 04/21/2005 | WO2004078918A3 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
| 04/21/2005 | WO2004078594A3 Ligand/binding partner bio-labeling systems |
| 04/21/2005 | WO2004073657A3 Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases |